Cormedics Corporation

Cormedics Corp. is a medical device company focused on developing technologies that selectively treat the heart with drug, cell, gene, and device therapies by introduction into the pericardial space. Cormedics develops medical technologies that focus on putting more control into the hands of those who treat cardiac patients. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes. Cormedics has four major focus areas that include: cardiac rhythm management, atrial fibrillation, pericardial effusion, and targeted cardiac drug and stem cell delivery.